Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Application of Megavoltage Imaging to Reduce Artifact After Seed Implants

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01810627
Recruitment Status : Completed
First Posted : March 13, 2013
Last Update Posted : September 26, 2017
Sponsor:
Information provided by (Responsible Party):
William St Clair, University of Kentucky

Brief Summary:
This is a non-randomized study to evaluate the utility of MVCT as a quality assurance measure in patients treated with interstitial permanent seed implants for low and intermediate risk prostate cancer. All patients will received the same standard of care treatment but will receive an additinoal CT image of the prostate.

Condition or disease Intervention/treatment
Prostate Cancer Radiation: MVCT

Layout table for study information
Study Type : Observational
Actual Enrollment : 10 participants
Official Title: Application of Megavoltage Imaging to Reduce Artifact Following Interstitial Seed Implants for Prostate Adenocarcinoma
Study Start Date : September 2013
Actual Primary Completion Date : April 2016
Actual Study Completion Date : April 2016

Resource links provided by the National Library of Medicine


Group/Cohort Intervention/treatment
MVCT
Patients will receive an additional MVCT scan at their one month follow up visit.
Radiation: MVCT
Patients will receive an additional MVCT scan at their one month follow up visit.




Primary Outcome Measures :
  1. Change in prostate volume measured in cm^3 [ Time Frame: One month post implant ]
    Change in prostate volume measured with trans-rectal ultrasound at baseline versus prostate volume measured with KVCT and MVCT.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Male 50-80 years of age Eligible for interstitial brachytherapy implants

Exclusion Criteria:

-


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01810627


Locations
Layout table for location information
United States, Kentucky
Markey Cancer Center
Lexington, Kentucky, United States, 40536
Sponsors and Collaborators
William St Clair
Investigators
Layout table for investigator information
Principal Investigator: William St. Clair, MD Lucille P. Markey Cancer Center at University of Kentucky

Layout table for additonal information
Responsible Party: William St Clair, Faculty, Radiation Medicine, University of Kentucky
ClinicalTrials.gov Identifier: NCT01810627     History of Changes
Other Study ID Numbers: 13-RAD-01
First Posted: March 13, 2013    Key Record Dates
Last Update Posted: September 26, 2017
Last Verified: September 2017
Keywords provided by William St Clair, University of Kentucky:
Prostate
Cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases